Suicide — CA-LINC Black Youth Suicide Detection and Intervention Study
Citation(s)
Gryglewicz K, Peterson A, Nam E, Vance MM, Borntrager L, Karver MS Caring Transitions - A Care Coordination Intervention to Reduce Suicide Risk Among Youth Discharged From Inpatient Psychiatric Hospitalization. Crisis. 2023 Jan;44(1):7-13. doi: 10.1027/0227-5910/a000795. Epub 2021 Jun 15.
Richardson SC, Gunn LH, Phipps M, Azasu E Factors Associated with Suicide Risk Behavior Outcomes Among Black High School Adolescents. J Community Health. 2023 Dec 14. doi: 10.1007/s10900-023-01312-7. Online ahead of print.
Vance MM, Gryglewicz K, Nam E, Richardson S, Borntrager L, Karver MS Exploring Service Use Disparities among Suicidal Black Youth in a Suicide Prevention Care Coordination Intervention. J Racial Ethn Health Disparities. 2023 Oct;10(5):2231-2243. doi: 10.1007/s40615-022-01402-7. Epub 2022 Sep 13.
CA-LINC: A Culturally Adapted Care Coordination Suicide Detection and Intervention Model for Black Youth
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
